Bryn Mawr Capital Management LLC lessened its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 76.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,546 shares of the company’s stock after selling 8,136 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Colgate-Palmolive were worth $231,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of CL. Union Bancaire Privee UBP SA purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $32,000. Hager Investment Management Services LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $36,000. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter worth about $42,000. Roxbury Financial LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $43,000. Finally, Synergy Asset Management LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $49,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Up 1.9 %
Shares of NYSE CL opened at $89.56 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 52 week low of $84.45 and a 52 week high of $109.30. The firm’s fifty day moving average is $88.94 and its 200 day moving average is $95.91. The company has a market cap of $72.68 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 4.18 and a beta of 0.44.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on CL. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. Piper Sandler lowered their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, UBS Group lowered their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $101.16.
Get Our Latest Stock Analysis on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- How to Invest in the Best Canadian StocksĀ
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Stock Sentiment Analysis: How it Works
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.